Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Prostatic Neoplasms 17Neoplasm Metastasis 2Sarcoma, Ewing 1Sarcoma 1Osteosarcoma 1Neoplasms 1Lymphoma 1Hematopoietic and Lymphatic System Neoplasm 1Breast Neoplasms 1

Interventions

Practice Guidelines as Topic 7Interviews as Topic 7Standard of Care 6Specimen Handling 6Educational Status 4Patient Navigation 3Telemedicine 2Methods 2Health Promotion 2Early Intervention, Educational 2Behavior Therapy 2theanine 1ruxolitinib 1merphos 1Triptorelin Pamoate 1Spinal Puncture 1Parenteral Nutrition, Total 1Parenteral Nutrition 1Organizational Objectives 1Mindfulness-Based Stress Reduction 1Mindfulness 1Methotrexate 1Meditation 1Massage 1Hydrocortisone 1Genetic Testing 1Exercise Test 1Dietary Supplements 1Dietary Fiber 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hematopoietic and Lymphatic System Neoplasm × Triptorelin Pamoate × Clear all
NCT06513962 2026-05-05

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

Children's Oncology Group

Phase 3 Recruiting
60 enrolled
Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡